ATE316378T1 - Schlafmittel enhaltend prostaglandinderivate - Google Patents

Schlafmittel enhaltend prostaglandinderivate

Info

Publication number
ATE316378T1
ATE316378T1 AT99921249T AT99921249T ATE316378T1 AT E316378 T1 ATE316378 T1 AT E316378T1 AT 99921249 T AT99921249 T AT 99921249T AT 99921249 T AT99921249 T AT 99921249T AT E316378 T1 ATE316378 T1 AT E316378T1
Authority
AT
Austria
Prior art keywords
group
inderivatives
prostagland
cycloalkyl
agents containing
Prior art date
Application number
AT99921249T
Other languages
English (en)
Inventor
Fumie Sato
Tohru Tanami
Kazuya Kameo
Kenji Yamada
Shigeru Okuyama
Naoya Ono
Original Assignee
Taisho Pharmaceutical Co Ltd
Fumie Sato
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd, Fumie Sato filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE316378T1 publication Critical patent/ATE316378T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99921249T 1998-05-25 1999-05-25 Schlafmittel enhaltend prostaglandinderivate ATE316378T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14262298 1998-05-25

Publications (1)

Publication Number Publication Date
ATE316378T1 true ATE316378T1 (de) 2006-02-15

Family

ID=15319631

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99921247T ATE252555T1 (de) 1998-05-25 1999-05-25 Prostaglandinderivate
AT99921249T ATE316378T1 (de) 1998-05-25 1999-05-25 Schlafmittel enhaltend prostaglandinderivate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT99921247T ATE252555T1 (de) 1998-05-25 1999-05-25 Prostaglandinderivate

Country Status (14)

Country Link
US (2) US6329539B1 (de)
EP (2) EP1082961B1 (de)
JP (3) JP4354644B2 (de)
KR (2) KR100623941B1 (de)
CN (2) CN1144588C (de)
AT (2) ATE252555T1 (de)
AU (2) AU742118B2 (de)
CA (2) CA2334355C (de)
DE (2) DE69912277T2 (de)
DK (1) DK1083168T3 (de)
ES (2) ES2211083T3 (de)
HK (2) HK1037535A1 (de)
PT (1) PT1083168E (de)
WO (2) WO1999061419A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01008955A (es) 1999-03-05 2002-04-24 Procter & Gamble Analogos de prostaglandinas selectivas de fp no saturadas de c16.
CA2389869A1 (en) 1999-11-24 2001-05-31 Taisho Pharmaceutical Co., Ltd. Preparation for nasal administration
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
MXPA04002006A (es) 2001-08-31 2004-06-07 Sucampo Ag Analogos de prostagladina como abridor del canal de cloruro.
WO2003048140A1 (fr) * 2001-12-03 2003-06-12 Japan Tobacco Inc. Compose azole et utilisation medicinale de celui-ci
US20040266880A1 (en) * 2002-02-22 2004-12-30 Fumie Sato Antipruritics
EP1553083B1 (de) * 2002-07-12 2009-08-26 Taisho Pharmaceutical Co., Ltd Prostaglandinderivate
US7737182B2 (en) * 2002-08-09 2010-06-15 Taisho Pharmaceutical Co., Ltd. Pharmaceuticals for xerosis
EP1527781B1 (de) * 2002-08-09 2008-07-23 Taisho Pharmaceutical Co., Ltd Antipruritisches mittel
US7037522B2 (en) * 2002-09-27 2006-05-02 Western Holdings, L.L.C. Nocturnal muscle enhancing composition and method
AU2003301900A1 (en) * 2002-11-13 2004-06-03 Fumie Sato Antipruritic drug
US20060270740A1 (en) * 2003-02-20 2006-11-30 Taisho Pharmaceutical Co., Ltd. And Fumie Sato Prostaglandin derivatives
WO2004089918A1 (ja) * 2003-04-09 2004-10-21 Japan Tobacco Inc. 複素芳香５員環化合物及びその医薬用途
JP5382898B2 (ja) * 2004-02-06 2014-01-08 大正製薬株式会社 乾皮症治療剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07103096B2 (ja) 1987-01-28 1995-11-08 株式会社上野製薬応用研究所 プロスタグランジンｄ類およびそれを含む鎮静・睡眠剤
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
DE4036140A1 (de) * 1990-11-09 1992-05-14 Schering Ag 9-halogen-11ss-hydroxy-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69214953T2 (de) 1991-04-22 1997-02-20 Taiho Pharmaceutical Co Ltd Prostaglandin e1-analoge
JPH05117230A (ja) 1991-04-22 1993-05-14 Taisho Pharmaceut Co Ltd プロスタグランジン誘導体
EP0652211A1 (de) * 1992-07-24 1995-05-10 Taisho Pharmaceutical Co. Ltd Prostaglandinderivat
JP3408835B2 (ja) 1993-03-23 2003-05-19 大正製薬株式会社 Ｅ型プロスタグランジン類の製造方法
JP3579448B2 (ja) * 1993-12-29 2004-10-20 大正製薬株式会社 プロスタグランジン誘導体、その塩およびその使用
JP3506485B2 (ja) * 1994-04-19 2004-03-15 大正製薬株式会社 プロスタグランジン誘導体
US5599838A (en) * 1996-02-23 1997-02-04 Taisho Pharmaceutical Co., Ltd. Prostaglandin derivatives

Also Published As

Publication number Publication date
CA2333038A1 (en) 1999-12-02
US6329539B1 (en) 2001-12-11
KR20010043596A (ko) 2001-05-25
ATE252555T1 (de) 2003-11-15
HK1037610A1 (en) 2002-11-08
AU742232B2 (en) 2001-12-20
CN1144588C (zh) 2004-04-07
CA2333038C (en) 2008-12-02
DE69929594D1 (de) 2006-04-13
CA2334355A1 (en) 1999-12-02
DK1083168T3 (da) 2003-12-15
KR20010043595A (ko) 2001-05-25
AU742118B2 (en) 2001-12-20
EP1082961A4 (de) 2001-07-11
WO1999061029A1 (fr) 1999-12-02
JP4354644B2 (ja) 2009-10-28
HK1037535A1 (en) 2002-11-08
CN1303292A (zh) 2001-07-11
CN1303370A (zh) 2001-07-11
KR100623941B1 (ko) 2006-09-13
WO1999061419A1 (fr) 1999-12-02
DE69912277T2 (de) 2004-07-15
US6395786B1 (en) 2002-05-28
JP2000044477A (ja) 2000-02-15
EP1083168B1 (de) 2003-10-22
EP1082961A1 (de) 2001-03-14
ES2257860T3 (es) 2006-08-01
JP4409767B2 (ja) 2010-02-03
ES2211083T3 (es) 2004-07-01
EP1083168A4 (de) 2002-09-04
KR100570521B1 (ko) 2006-04-12
AU3851499A (en) 1999-12-13
CN1144783C (zh) 2004-04-07
DE69912277D1 (de) 2003-11-27
DE69929594T2 (de) 2006-12-07
EP1083168A1 (de) 2001-03-14
PT1083168E (pt) 2004-03-31
EP1082961B1 (de) 2006-01-25
CA2334355C (en) 2009-01-27
AU3851299A (en) 1999-12-13

Similar Documents

Publication Publication Date Title
ATE316378T1 (de) Schlafmittel enhaltend prostaglandinderivate
DE69716226T2 (de) Difluoroprostaglandin-Derivate und ihre Anwendung
DE69828284D1 (de) Naphthyridinderivate oder salze davon
NO972887L (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
ES2046641T3 (es) Composicion antitumoral.
CA2014521A1 (en) 2-Substituted N,N'-Ditrimethoxybenzoyl Piperazines, a Preparation Process of the Same and Therapeutic Compositions Containing Them
DE60043702D1 (de) Prostaglandin-derivate
NO20006350L (no) Derivater av 3-(2-okso-[1,3']bipyrrolidinyl-3-ylidenmetyl)- cephemer
EA200500032A1 (ru) Производные ацилоксипирролидина и их применение в качестве лигандов v1b или v1b и v1a рецепторов
DK0420224T3 (da) Anthihepatopatisk middel
EA199900460A1 (ru) Производные бензолсульфоамида и лекарственные средства, содержащие упомянутые производные
HUP9802938A2 (hu) 4-Cikloalkil-piperidin és 4-cikloalkil-alkil-piperidin-származékok, eljárás a vegyületek előállítására és a vegyületek alkalmazása a gyógyászatban
ATE86629T1 (de) 4-piperidincarboxamid-derivate.
ATE440818T1 (de) Prostaglandinderivate
DE69033459T2 (de) Prostaglandin-I-Analoga
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DE69424677D1 (de) Präparat zur behandlung der drogenabhängigkeit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties